115th Congress

Washington, D.C. – The House Judiciary Committee today approved the Injunctive Authority Clarification Act of 2018 (H.R.6730) by a vote of 14-6.

Washington, D.C. – House Judiciary Committee Chairman Bob Goodlatte (R-Va.) today delivered the following statement during the Committee’s markup of the Injunctive Authority Clarification Act of 2018 (H.R.6730).

Washington, D.C. - The House Judiciary Committee today approved by voice vote the Judiciary Reform, Organization and Operational Modernization (ROOM) Act of 2018, H.R. 6755. This bill, authored by Courts, Intellectual Property, and the Internet Subcommittee Chairman Darrell Issa (R-Calif.), increases the number of federal district court judges by adopting the 2017 district court judgeship recommendations of the Judicial Conference in their entirety and includes several measures designed to improve the operation of the federal court system. The U.S.

Washington, D.C. - The House Judiciary Committee today approved by voice vote the bipartisan Study of Underrepresented Classes Chasing Engineering and Science Success (SUCCESS) Act, H.R. 6758. This bill, authored by Congressman Steve Chabot (R-Ohio), a senior Member of the House Judiciary Committee and Chairman of the House Small Business Committee, would reauthorize the U.S.

Washington, D.C. . – House Judiciary Committee Chairman Bob Goodlatte (R-Va.) today delivered the following statement during the Committee’s markup of the Study of Underrepresented Classes Chasing Engineering and Science Success (SUCCESS) Act, H.R. 6758.

Washington, D.C. – The House Judiciary Committee today approved by voice vote the Medical Cannabis Research Act of 2018 (H.R. 5634). This narrowly tailored, bipartisan bill is designed to facilitate and encourage federally-approved clinical trials testing the potential medicinal effects of chemicals found in the marijuana plant. Specifically, the Medical Cannabis Research Act increases the number of federally-approved manufacturers of research-grade marijuana from one to three, and would set strict criteria for those manufacturers to obtain and renew their registrations.

Washington, D.C. – House Judiciary Committee Chairman Bob Goodlatte (R-Va.) today delivered the following statement during the Committee’s markup of the Medical Cannabis Research Act of 2018 (H.R. 5634).

Washington, D.C. -- On Friday, September 28, 2018 at 9:00 a.m.